D107 DIAMONDS AND PEARLS: PULMONARY HYPERTENSION PHENOTYPES: Risk Of Pulmonary Hypertension In Users Of Prescription Amphetamine-Based Stimulants: A Single Center Experience

Using electronic health record data from a large healthcare delivery system in Northern California, we tested the hypothesis that use of PABS is associated with increased risk of developing PH. Outcomes were ICD-9-documented diagnoses for WHO group 1 PH (idiopathic pulmonary arterial hypertension (i...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of respiratory and critical care medicine Vol. 195
Main Authors Stewart, E M, Rajasingh, C M, Hedlin, H, Romanelli, R J, Wilson, S R, Perez, V De Jesus, Zamanian, R T
Format Journal Article
LanguageEnglish
Published New York American Thoracic Society 01.01.2017
Subjects
Amphetamines
Females
Pulmonary hypertension
Northern California
Online AccessGet full text

Cover

More Information
Summary:Using electronic health record data from a large healthcare delivery system in Northern California, we tested the hypothesis that use of PABS is associated with increased risk of developing PH. Outcomes were ICD-9-documented diagnoses for WHO group 1 PH (idiopathic pulmonary arterial hypertension (iPAH; 416.0) or associated with other causes (APAH; 416.8) specifically excluding risk factors for WHO group 2-5 PH based on ICD-9 code.
ISSN:1073-449X
1535-4970